Omega-3 fatty acids in food and pharma: The enabling role of biotechnology

Peter J. Gillies, William S. Harris, Penny Margaret Kris-Etherton

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Omega-3 fatty acid research, which began as an epidemiologic curiosity, has generated perhaps the strongest dataset for any nutrient in regard to cardiovascular disease risk reduction. Although once a relatively descriptive field, advances in analytic techniques have opened up the biochemistry of omega-3 fatty acids and nutritional genomics in plants and man and have taken the field into the "omic" era. Despite this progress, fundamental questions remain unanswered, such as which fatty acid or metabolite thereof drives a given health benefit, how much of a given fatty acid should we consume, and how do we best source the requisite fatty acids? Of these questions, the ability to source omega-3 fatty acids in order to meet dietary guidelines has become a practical concern. The advent of novel oils from plants and single cell organisms as enabled by biotechnology may provide a solution to this problem and in the process open up new uses for omega-3 fatty acids in dietary supplements and drugs.

Original languageEnglish (US)
Pages (from-to)467-473
Number of pages7
JournalCurrent atherosclerosis reports
Volume13
Issue number6
DOIs
StatePublished - Dec 1 2011

Fingerprint

Omega-3 Fatty Acids
Biotechnology
Food
Fatty Acids
Nutrigenomics
Nutrition Policy
Exploratory Behavior
Aptitude
Plant Cells
Insurance Benefits
Risk Reduction Behavior
Dietary Supplements
Biochemistry
Oils
Cardiovascular Diseases
Research
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

@article{8a3fe319ff5742038e6b394932fc088a,
title = "Omega-3 fatty acids in food and pharma: The enabling role of biotechnology",
abstract = "Omega-3 fatty acid research, which began as an epidemiologic curiosity, has generated perhaps the strongest dataset for any nutrient in regard to cardiovascular disease risk reduction. Although once a relatively descriptive field, advances in analytic techniques have opened up the biochemistry of omega-3 fatty acids and nutritional genomics in plants and man and have taken the field into the {"}omic{"} era. Despite this progress, fundamental questions remain unanswered, such as which fatty acid or metabolite thereof drives a given health benefit, how much of a given fatty acid should we consume, and how do we best source the requisite fatty acids? Of these questions, the ability to source omega-3 fatty acids in order to meet dietary guidelines has become a practical concern. The advent of novel oils from plants and single cell organisms as enabled by biotechnology may provide a solution to this problem and in the process open up new uses for omega-3 fatty acids in dietary supplements and drugs.",
author = "Gillies, {Peter J.} and Harris, {William S.} and Kris-Etherton, {Penny Margaret}",
year = "2011",
month = "12",
day = "1",
doi = "10.1007/s11883-011-0206-z",
language = "English (US)",
volume = "13",
pages = "467--473",
journal = "Current Atherosclerosis Reports",
issn = "1523-3804",
publisher = "Current Medicine Group",
number = "6",

}

Omega-3 fatty acids in food and pharma : The enabling role of biotechnology. / Gillies, Peter J.; Harris, William S.; Kris-Etherton, Penny Margaret.

In: Current atherosclerosis reports, Vol. 13, No. 6, 01.12.2011, p. 467-473.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Omega-3 fatty acids in food and pharma

T2 - The enabling role of biotechnology

AU - Gillies, Peter J.

AU - Harris, William S.

AU - Kris-Etherton, Penny Margaret

PY - 2011/12/1

Y1 - 2011/12/1

N2 - Omega-3 fatty acid research, which began as an epidemiologic curiosity, has generated perhaps the strongest dataset for any nutrient in regard to cardiovascular disease risk reduction. Although once a relatively descriptive field, advances in analytic techniques have opened up the biochemistry of omega-3 fatty acids and nutritional genomics in plants and man and have taken the field into the "omic" era. Despite this progress, fundamental questions remain unanswered, such as which fatty acid or metabolite thereof drives a given health benefit, how much of a given fatty acid should we consume, and how do we best source the requisite fatty acids? Of these questions, the ability to source omega-3 fatty acids in order to meet dietary guidelines has become a practical concern. The advent of novel oils from plants and single cell organisms as enabled by biotechnology may provide a solution to this problem and in the process open up new uses for omega-3 fatty acids in dietary supplements and drugs.

AB - Omega-3 fatty acid research, which began as an epidemiologic curiosity, has generated perhaps the strongest dataset for any nutrient in regard to cardiovascular disease risk reduction. Although once a relatively descriptive field, advances in analytic techniques have opened up the biochemistry of omega-3 fatty acids and nutritional genomics in plants and man and have taken the field into the "omic" era. Despite this progress, fundamental questions remain unanswered, such as which fatty acid or metabolite thereof drives a given health benefit, how much of a given fatty acid should we consume, and how do we best source the requisite fatty acids? Of these questions, the ability to source omega-3 fatty acids in order to meet dietary guidelines has become a practical concern. The advent of novel oils from plants and single cell organisms as enabled by biotechnology may provide a solution to this problem and in the process open up new uses for omega-3 fatty acids in dietary supplements and drugs.

UR - http://www.scopus.com/inward/record.url?scp=81155133750&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=81155133750&partnerID=8YFLogxK

U2 - 10.1007/s11883-011-0206-z

DO - 10.1007/s11883-011-0206-z

M3 - Article

C2 - 21892757

AN - SCOPUS:81155133750

VL - 13

SP - 467

EP - 473

JO - Current Atherosclerosis Reports

JF - Current Atherosclerosis Reports

SN - 1523-3804

IS - 6

ER -